Literature DB >> 2772822

Aggressive surgery for carcinoma of the gallbladder.

S Nakamura1, S Sakaguchi, S Suzuki, H Muro.   

Abstract

Forty patients with gallbladder cancer were admitted to our institution in a 9-year period. For two patients with Nevin's stage I carcinoma who had undergone cholecystectomy, resection of the lower portion of the fourth and fifth segments of the liver and extrahepatic bile duct with dissection of lymph nodes was carried out as a second-stage operation. Thirteen patients with stage V carcinoma underwent extensive aggressive operations. Operative procedures comprised various types of liver resection with cholecystectomy and extrahepatic bile duct resection and wide lymph node dissection in all cases, portal vein reconstruction in 3, pancreatoduodenectomy in 3, partial colectomy in 3, and right nephrectomy in 1. The operative and in-hospital mortality rates were 0%. Two patients with stage I carcinoma are both doing well. Two patients with stage V carcinoma who underwent an extended operation are working without recurrence 7 years 8 months and 8 years 5 months after surgery. From our experiences we believe that long-term survival may be achieved by aggressive surgery if it is suitably indicated.

Entities:  

Mesh:

Year:  1989        PMID: 2772822

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  30 in total

1.  Partial portal arterialization for the prevention of massive liver necrosis following extended pancreatobiliary surgery: experience of two cases.

Authors:  J Iseki; K Touyama; T Noie; K Nakagami; M Takagi; K Hakamada; A Tanaka; A Yamada; J Hanakita; H Suwa
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

2.  Surgery for gallbladder cancer: The need to generate greater evidence.

Authors:  Shailesh V Shrikhande; Savio G Barreto
Journal:  World J Gastrointest Surg       Date:  2009-11-30

3.  Extra-Hepatic Bile Duct Resection: an Insight in the Management of Gallbladder Cancer.

Authors:  Durgatosh Pandey; Pankaj Kumar Garg; N M L Manjunath; Jyoti Sharma
Journal:  J Gastrointest Cancer       Date:  2015-09

4.  Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention.

Authors:  Y Fong; W Jarnagin; L H Blumgart
Journal:  Ann Surg       Date:  2000-10       Impact factor: 12.969

5.  Gallbladder carcinoma with biliary invasion: clinical analysis of the differences from nonbiliary invasion.

Authors:  Kun-Ming Chan; Ta-Sen Yeh; Ming-Chin Yu; Yi-Yin Jan; Tsann-Long Hwang; Miin-Fu Chen
Journal:  World J Surg       Date:  2005-01       Impact factor: 3.352

6.  Extended cholecystectomy for carcinoma of the gallbladder.

Authors:  H Onoyama; M Yamamoto; A Tseng; T Ajiki; Y Saitoh
Journal:  World J Surg       Date:  1995 Sep-Oct       Impact factor: 3.352

7.  Extent of resection for T2N0 gallbladder carcinoma regarding concurrent extrahepatic bile duct resection.

Authors:  Sung-Chan Gwark; Shin Hwang; Ki-Hun Kim; Yong-Joo Lee; Kwang-Min Park; Chul-Soo Ahn; Deok-Bog Moon; Tae-Yong Ha; Gi-Won Song; Dong-Hwan Jung; Gil-Chun Park; Sung-Gyu Lee
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2012-11-30

Review 8.  Surgical management of gallbladder carcinoma: a review.

Authors:  Kristin L Mekeel; Alan W Hemming
Journal:  J Gastrointest Surg       Date:  2007-09       Impact factor: 3.452

9.  Assessing the impact of common bile duct resection in the surgical management of gallbladder cancer.

Authors:  Faiz Gani; Stefan Buettner; Georgios A Margonis; Cecilia G Ethun; George Poultsides; Thuy Tran; Kamran Idrees; Chelsea A Isom; Ryan C Fields; Bradley Krasnick; Sharon M Weber; Ahmed Salem; Robert C G Martin; Charles Scoggins; Perry Shen; Harveshp D Mogal; Carl Schmidt; Eliza Beal; Ioannis Hatzaras; Rivfka Shenoy; Shishir K Maithel; Timothy M Pawlik
Journal:  J Surg Oncol       Date:  2016-05-20       Impact factor: 3.454

10.  Radical surgery for gallbladder carcinoma. Long-term results.

Authors:  Y Shirai; K Yoshida; K Tsukada; T Muto; H Watanabe
Journal:  Ann Surg       Date:  1992-11       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.